Fifth Dimension Site Map Search Contact Us
|
|||
|
References - Traditional Chinese Medicine in the Treatment of Breast Cancer |
||
|
|||
(Part 1) References
Back to the Table of Contents
1 Eisenberg DM, Davis RB, Ettner SL et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA. 1998 Nov 11;280(18):1569-75.
2 Eisenberg DM, Kessler RC, Foster C. et al. Unconventional medicine in the United States. Prevalence, costs, and patterns of use. N Engl J Med. 1993 Jan 28;328(4):246-52.
3 Olayiwola, A. WHO guidelines for the assessment of herbal medicines. ESCOP Symposium: The scientific assessment of phytomedicines. Milan, Italy, 13 March, 1992. Fitoterapia Vol. 1, XIII, No. 2, 1992
4 Balandrin, M.F., J.A. Kjocke, E.S. Wurtele, and W.H. Bollinger. 1985. Natural plant chemicals: sources of industrial and medicinal materials. Science. 228: 1154-1160.
5 ONeil MJ, Lewis JA. In Human Medicinal Agents from Plants; Kinghorn AD, Balandrin MF, Eds; ACS Symposium Series 534; American Chemical Society: Washington, D.C. 1993; pp 48-55.
6 Cragg, G.M., D.J. Newman, and K.M. Sander. 1997. Natural Products in Drug Discovery and Development. J. Natural Products. 60: 52-60.
7 Cragg, G.M., S.A. Schepartz, M. Suffness, and M.R. Grever. 1993. The taxol supply crisis: new NCI policies for handling the large scale production of novel natural product anticancer and anti-HIV agents. J Nat. Prod. 56: 1657-1668.
8 Zhang DZ. The Treatment of Cancer by Integrated Chinese Western Medicine. Blue Poppy Press, Boulder,CO, 1989, p. 1-2.
9 Wu JN (trans.). Ling Shu or The Spiritual Pivot. The Taoist Center, Washington, D.C., 1993. p. 274.
10 Fu QZ (1607-1684 CE) (Yang S. Liu D. Trans.). Fu Qing Zhus Gynecology. Blue Poppy Press, Boulder, CO, 1992, p. 248-50.
11 Zhu DX (1281-1358 CE) (Yang S. Trans.) The Heart and Essence of Danxis Methods of Treatment. Blue Poppy Press, Boulder, CO, 1993, p.313-316.
12 Zhang DZ. The Treatment of Cancer by Integrated Chinese Western Medicine. Blue Poppy Press, Boulder, CO, 1989, p. 2-13
13 Shi L, Shi P. Experince in Treating Carcinoma with Traditional Chinese Medicine. Shandong Science and Technology Press, Shandong, 1990.
14 Xie W. Cancer = Death?: Treatment of Cancer the Chinese Way. New World Press, Beijing, 1997
15 Cheung CS. Breast cancer supportive management: A collective works from TCM practitioners of China, Harmonious Sunshine Press, 1999.
16 Zhou M, Wu YH, Liu YD. Integrated Chinese-western medicine treatments for advanced stage breast cancer: an analysis of 14 cases. China Integrated Chinese-Western Medicine Journal, 1995, 15(4): 237.
17 Yin XD. An Analysis of 32 cases of breast cancer treated with combination of FACT and Kang Lai Te injection. Ji Lu Tumour Journal, 1999, 6(2): 158-159. (Chinese)
18 An Analysis of 134 Cases of Breast Cancer Treated with Chinese- Western Integrated Medicine. Chinese Medicine Journal, 1985, 13(2): 111. No author noted. (Chinese)
19 Lei QM, Song JS, Fan DN et al. Observations on 77 Cases of Breast Cancer Treated with the Chinese Herb Teng Huang. Cancer Prevention Research, 1986, 13 (2): 111. (Chinese)
20 Yang GJ, Zhao l. Observations on the Results of 216 Cases of Breast Cancer treated with Combined Chinese-Western Medicine. Intermediate Medical Periodical, 1988, 23 (8): 48-50. (Chinese)
21 Shen SY, Jiang CY. 14 Cases of Breast Disease Treated with a Combination of Hai Zao and Gan Cao. Chinese Medical News, 1990, 7(2): 40-41. (Chinese)
22 Wang Q, He SJ. 31 Cases of Breast Cancer Treated with Integrated Chinese-Western Medicine. Cancer, 1990, 9 (3): 238. (Chinese)
23 Guo T, Xu B, Yan SQ et al. Neoadjuvant chemotherapy of advanced breast cancer (stage III). Qingdao Tumour Hospital, Shandong, 2000. (Chinese)
24 Niu DL et al. Curative observation on effects of Chinese herbs and western drugs applied to quench vomiting caused by tumour chemotherapy. Ch J Integ TCM-WM, 1995, 15(7): 397
25 Liu M, Yao M, Shen P. Personal experience in herbal treatment of postoperative breast cancer. Affiliated Longhua Hospital, Shanghai College of TCM, 1996. (Translated for the author by Dr.Li PP, Chief, Department of TCM, The School of Oncology, Beijing Medical University, Beijing Institute for Cancer Research, Beijing, China)
26 Fan C. 30 cases of breast cancer treated by herbal medicines during chemotherapy after surgery. 1996. (Ibid)
27 Li P, Wang X, Yu R et al. A study of breast cancer due to mental depression. Beijing TCM Hospital. 1996. (Ibid)
28 Liu S. Lu Demings experience in treatment of advanced metastatic breast cancer. 1996. (Ibid)
29 Ni M (trans.). The Yellow Emperrors Classic of Medicine. Shambhala, Boston, 1995.
30 Gao YT. Implications of the time trend of cancer incidence in urban Shanghai, China, for cancer. www.who.int/ncd/cancer/publications/abstracts.
31. WHO 2000.
32 Greenwald P. Experience from clinical trials in cancer prevention. Ann Med. 1994 Feb;26(1):73-80.
33 Nakachi K, Suemasu K, Suga K. et al. Influence of drinking green tea on breast cancer malignancy among Japanese patients. Jpn J Cancer Res. 1998 Mar;89(3):254-61.
34 Haagansen CD. Diseases of the Breast, 2nd edition, Philadelphia: WB Saunders, 1971.
35 Chardot C, Varroy A, Parache RM. Fibro-cystic mastosis and cancer (206 cases of mastosis in possible relation with 12 cases of cancer). Bull Cancer. 1970 Apr-Jun;57(2):251-68.
36 Roberts MM, Jones V, Elton RA et al. Risk of breast cancer in women with history of benign disease of the breast. Br Med J (Clin Res Ed). 1984 Jan 28;288(6413):275-8.
37 Bundred NJ, West RR, ODowd J et al. Is there an increased risk of breast cancer in women who have a breast cyst aspirated? Br J Cancer. 1991; 64: 953-55. 58 JOURNAL OF CHINESE MEDICINE NUMBER 68 FEBRUARY 2002
38 Bruzzi P, Dogliotti L, Naldoni C et al. Cohort study of association of risk of breast cancer with cyst type in women with gross cystic disease of the breast. BMJ. 1997 Mar 29;314(7085):925-8.
39 Dixon JM, McDonald C, Elton RA et al. Risk of breast cancer in women with palpable breast cysts: a prospective study. Edinburgh Breast Group. Lancet. 1999 May 22;353(9166):1742-5.
40 Flaws B. Chace C. Recent TCM Research From China-1991- 1994. Blue Poppy Press, Boulder CO. 1994, p. 86-99.
41 Ye X. Zhang G. Clinical experience in the treatment of120 cases of mammary neoplasia with ru tong ling (breast pain efficacious remedy). Tianjin J TCM 1994, 3:6.
42 Tan J, Feng Y. Analysis on 96 cases of masto-hyperplasia treated by point-injection. Chinese Acupuncture & Moxibustion, 1996; (7): 27-8.
43 El-Bastawissi AY, White E, Mandelson MT et al. Reproductive and hormonal factors associated with mammographic breast density by age (United States). Cancer Causes Control. 2000 Dec;11(10):955-63.
44 Rutter CM, Mandelson MT, Laya MB et al. Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapy. JAMA. 2001 Jan 10;285(2):171-6.
45 Martin CF, Peck JD, Pisano ED et al. Prior HRT use, ethnicity and mammographic breast density. AEP Vol. 10, No. 7, October 2000: 4461-2.
46 Laya MB, Gallagher JC, Schreiman JS et al. Effect of postmenopausal hormonal replacement therapy on mammographic density and parenchymal pattern. Radiology. 1995 Aug;196(2):433-7.
47 Maskarinec G, Meng L. An investigation of soy intake and mammographic characteristics in Hawaii. Breast Cancer Res. 2001;3(2):134-41.
48 Mandelson MT, Oestreicher N, Porter PL et al. Breast density as a predictor of mammographic detection: comparison of interval-and screen-detected cancers. J Natl Cancer Inst. 2000 Jul 5;92(13):1081-7.
49 Yin K. Observation on curative effect of xiao he ling applied to treat 460 patients of mastoplasia. Gansu J TCM 1995, 8(1): 30-1.
50 Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists Collaborative Group. Lancet. 1998 Sep 19;352(9132):930-42.
51 SEER database 2000
52 Pan M. Cancer Treatment with Fu Zheng Pei Ben Principle. Fujian Science and Technology Publishing House, Fujian, 1992, p. 225-38.
53 Yu G, Liang F, Zhang D. The Combined TCM-WM prevention and treatment of malignant tumour marching towards 21st century.International Conference on Prevention and Treatment of Cancer with TCM-WM 1998, p.171.
54. Zhang D. Preventing and treating side-effects by chemo-and/ or radiotherapy over the past 40 years. International Conference on Prevention and Treatment of Cancer with TCM-WM 1998,p.174.
55 Liu M, Yao M, Shen P. Personal experience in herbal treatment of post-operative breast cancer. Affiliated Longhua Hospital, Shanghai College of TCM, 1991.
56 Wang G, Zhao L, Xu G. Observation on the Results of 216 Cases of Breast Cancer Treated with Integrated Chinese- Western Medicine China Chinese Medicine Research Institute, Guang An Men Hospital. Intermediate Medical Periodical [Zhong Ji Yi Kan] 1988, 23(8).
57 Yin X, Liu S, Tong J, et al An Analysis of 32 Cases of Breast Cancer Treated with a Combination of FACT and Kang Lai Te Injection. Qilu Journal of Oncology [Qi Lu Zhong Liu Za Zhi] 1999, Vol.6, No.2
58 Zhu YP. Chinese Materia Medica: Chemistry, Pharmacology and Application. Harwood Academic Publishers, 1998, p. 319-20.
59 Yang H, Wang X, Yu L et al. Effects of Kang Lai Te (KLT) injection on cell proliferation kinetics and modulation of doxorubicin resistance. Kang Lai Te Injection: Pharmacology and Clinical Application, Cancer Institute, Zhejiang Medical University, 1999, p. 363-6
60 Han R. Developments in research on anti-cancer Chinese herbs. China New Herbs Journal (zhong guo xin yao za zhi), 1993, 2 (5): 1-7.
61 MJ Campbell, I Cohen, Hamilton B, Tagliaferri M, Shumaker M, Tripathy D. Antiproliferative Effects of Chinese Medicinal Herbs on Breast Cancer Cells, Proceedings of the American Association of Cancer Research (AACR)
62 Lei Q, Song Q, Fa D, et al. Observations on 77 cases of Breast Cancer Treated with the Chinese Herb Teng Huang. Jiang Xi Province Committee on Teng Hunag Anti-cancer Research. Cancer Prevention and Treatment Research: 1986, 13(2)
63 Zhou M, Wu Y, Liu Y. Integrated Chinese-Western Medicine Treatment for Late-Stage Breast Cancer: An Analysis of 14 Cases. Zhong Guo Zhong Xi Yi Jie He Za Zhi [China Integrated Medicine Journal] 1995, 15(4)
64 Chinese Medicine Research Institute, Guang An Men Hospital Oncology Department. An Analysis of 134 Cases of Breast Cancer Treated with Chinese-Western Integrated Medicine. Zhong Yi Zha Zhi [Chinese Medicine Journal] 1985, 26 (3)
65 Wang Q, He S. 31 cases of breast cancer treated with integrated Western-Chinese medicine. Ai Zheng [Cancer], 1990, 9(3): 238.
66 Tagliaferri M, Cohen I, Tripathy D. Complimentary and alternative medicine in early stage breast cancer. Seminars in Oncology 2001, 28(1): 121-134.
67 Vickers A, Goyal N, Harland R, et al. Do certain countries produce only positive results? A systematic review of controlled trials. Controlled Clinical Trials 1998, 19:159-166.
68 Tang J, Zhan S, Ernst E. Review of randomized controlled trials of traditional Chinese medicine. BMJ, 1999, 17 July, 319: 160-1.
69 Adler S. Complimentary and Alternative Medicine Use Among Women with Breast Cancer. Medical Anthropology Quarterly, 1999, 13 (2): 214-222.
70 Powell CB, Cohen I, DalEra J, et al: Use of Herbs in Women Diagnosed with Ovarian Cancer (pre-published data from survey) at UCSF-Mt. Zion Gynecological Cancer Center, 1999.
(Part 2) References
Back to the Table of Contents
1 Cohen I,Tagliaferri M,Tripathy D:Traditional Chinese Medicine in the treatment of breast cancer.The Journal of Chinese Medicine 68,Feb 2002,40-49. Traditional Chinese Medicine in the Treatment of Breast Cancer
2 Ernst E,Cassileth BR:The prevalence of complementary/ alternative medicine in cancer.Cancer 83:777-782,1998
3 Adler S:Complementary and alternative medicine use among women with breast cancer. Medical Anthropology Quarterly 13(2):214-222,1999
4 Lee M,Lin SS,Wrensch MR,et al:Alternative therapies used by women with breast cancer in four ethnic populations.J Natl Cancer Inst 92:42-47,2000
5 Powell CB, Dibble SL, Dall & Era JE et al:Use of herbs in women diagnosed with ovarian cancer.Int J Gynecol Cancer 2002 Mar; 12(2):214-217.
6 Cassileth BR,Lusk EJ,Strouse TB,et al:Contemporary unor- thodox treatments in cancer medicine:A study of patients, treatments and practitioners.Ann Intern Med 101:105-112,1984
7 Jacobson JS,Workman SB,Kronenber F:Research on complementary/alternative medicine for patients with breast cancer:A review of the biomedical literature.J Clin Oncol 18:668-683,2000
8 Kurtz JM, Spitalier JM,Amalric R:Late breast recurrence after lumpectomy and irradiation. Int J Radiat Oncol Biol Phys .1983 Aug;9(8):1191-4.
9 Straus K,Lichter A,Lippman M et al:Results of the National Cancer Institute early breast cancer trial. J Natl Cancer Inst Monogr.1992;(11):27-32.
10 Fowble B,Solin LJ,Schultz DJ et al:Breast recurrence and survival related to primary tumor location in patients undergoing conservative surgery and radiation for early-stage breast cancer. Int J Radiat Oncol Biol Phys .1992;23(5):933-9.
11 Solin LJ,Fowble BL,Schultz DJ et al:The significance of the pathology margins of the tumor excision on the outcome of patients treated with definitive irradiation for early stage breast cancer. Int J Radiat Oncol Biol Phys .1991 Jul;21(2):279-87.
12 Barth RJ Jr,Danforth DN Jr,Venzon DJ et al:Level of axillary involvement by lymph node metastases from breast cancer is not an independent predictor of survival. Arch Surg .1991 May;126(5):574-7.
13 Chauvet B,Reynaud-Bougnoux A,Calais G et al:Prognostic significance of breast relapse after conservative treatment in node-negative early breast cancer. Int J Radiat Oncol Biol Phys . 1990 Nov;19(5):1125-30.
14 Haffty BG,Goldberg NB,Fischer D et al:Conservative surgery and radiation therapy in breast carcinoma:local recurrence and prognostic implications .Int J Radiat Oncol Biol Phys .1989 Oct;17(4):727-32.
15 Neff PT,Bear HD,Pierce CV et al:Long-term results of breast conservation therapy for breast cancer. Ann Surg.1996 Jun;223(6):709-16;discussion 716-7.
16 Halverson KJ,Taylor ME,Perez CA et al:Survival following breast-conserving surgery and irradiation or modified radical mastectomy in patients with invasive breast cancers with a maximum diameter of 1 cm. Mo Med .1993 Dec;90(12):759-63.
17 Gan TJ,Duke U, ScienceDaily 2001
18 Zhu YP.Chinese Materia Medica:Chemistry,Pharmacology and Applications . Harwood Academic Publishers, Australia,1998.
19 Chang HM,But PPH.Pharmacology and Applications of Chinese Materia Medica ,Vol.I,II.World Scientific, Singapore, 1988.
20 Zhu YP.Chinese Materia Medica:Chemistry,Pharmacology and Applications . Harwood Academic Publishers, Australia, 1998 p.137,233
21 Chang HM,But PPH.Pharmacology and Applications of Chinese Materia Medica ,Vol.I,II.World Scientific,Singapore, 1988 p.72,1030
22 Hsu HY.Oriental Materia Medica:A Concise Guide .Oriental healing Arts Institute,Long Beach,CA,1986,p.93,156
23 Zhu YP.Chinese Materia Medica:Chemistry,Pharmacology and Applications . Harwood Academic Publishers, Australia, 1998 p.561.
24 Zhu YP.Chinese Materia Medica:Chemistry, Pharmacology and Applications . Harwood Academic Publishers,Australia, 1998 p.593.
25 Moran MS,Haffty BG.Local-regional breast cancer recurrence: prognostic groups based on patterns of failure. Breast J .2002 Mar-Apr;8(2):81-7.
26 Bartelink H,Horiot JC,Poortmans P.Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med .2001 Nov 8;345(19):1378-87.
27 Fisher B,Jeong JH,Dignam J.Findings from recent national surgical adjuvant breast and bowel project adjuvant studies in stage I breast cancer. J Natl Cancer Inst Monogr .2001;(30):62-6.
28 No Authors listed.National Institutes of Health Consensus Development Conference statement:adjuvant therapy for breast cancer,November 1-3,2000.J Natl Cancer Inst Monogr . 2001;(30):5-15.
29 Ben-Hur E.Fulder S.Effect of panax ginseng saponins and eleuthrococcus senticosus on survival of cultured mammalian cells after ionizing radiation.American J Chin Med 1981,9(1): 48-56.
30 Chen W.Hau D.Lee S. Effects of ganoderma lucidum and krestin on cellular immunocompetence in irradiated mice. American J Chin Med 1995,23(1):71-80.
31 Zhu YP.Chinese Materia Medica:Chemistry,Pharmacology and Applications. Harwood Academic Publishers,Australia, 1998.p.473,558,641,437,70,263,174,129.
32 Zhu YP.Chinese Materia Medica:Chemistry,Pharmacology and Applications . Harwood Academic Publishers, Australia, 1998.p.354,159.
33 Zhang D,Zheng X and Wang Q:Clinical study on climacteric syndrome treated by acupuncture and moxibustion.Shanghai Journal of Acupuncture and Moxibustion 1999,3:29-32.
34 Hsu H.Hau D.Lin C. Effect of kuei pi tang on cellular immunocompetence of irradiated mice.American J Chin Med 1993 ,21(2):151-8.
(Part 3) References
Back to the Table of Contents
1 Cohen I,Tagliaferri M,Tripathy D:Traditional Chinese Medicine in the treatment of breast cancer.The Journal of Chinese Medicine 68,Feb 2002,40-49. Traditional Chinese Medicine in the Treatment of Breast Cancer
2 Tagliaferri M. Cohen I. Tripathy D. Complementary and alternative medicine in early-stage breast cancer. Semin Oncol. 2001 Feb;28(1):121-34. Review.
3 Cheung CS. Breast cancer supportive management: A collective works from TCM practitioners of China, Harmonious Sunshine Press, 1999, 5-8, 10-15.
4 Wang YF et al. Clinical study on preventing and treating chemotherapy induced nausea and vomiting using supplemented Inula- Haematite decoction. Ch J Integ TCMWM, 1998, 18(5): 273- 275.
5 Li PP. Vomiting treated by TCM. Beijing Inst. For Cancer Res. 1995.
6 Zhou J. Li Z. Jin P. A clinical study on acupuncture for prevention and treatment of toxic side-effects during radiotherapy and chemotherapy. J of TCM 1999, 19(1): 16- 21.
7 Liu Z. Sun F. Li J. et al. Application of acupuncture and moxibustion for keeping shape. J TCM 1998, 18(4): 265- 271.
8 Li W. Lien EJ. Fu-Zhen herbs in the treatment of cancer. Oriental Healing Arts International Bulletin, 1986, 11(1): 1-8.
9 Jin H. Ginseng and astragalus combination and the defensive function of the body. Intnl J of Orient Med 1999, March 24(1): 21- 23.
10 Yata N. Tanaka O. The effects of saponins in promoting the solubility and absorption of drugs. Oriental Healing Arts International Bulletin, 1988 Feb. 13(1):13- 22.
11 Shen J, Wenger N, Glaspy J. et al. Electroacupuncture for control of myeloablative chemotherapy-induced emesis: A randomized controlled trial JAMA. 2000 Dec 6;284(21):2755-61.
12 Cohen I. The Treatment of Women With Breast Cancer Undergoing Chemotherapy with Fu Zheng Principles- Analysis and Description, California Journal of Oriental Medicine (CJOM), June 1998: 19-21
13 Zhu YP. Chinese Materia Medica: Chemistry, Pharmacology and Applications. Harwood Academic Publishers, Australia, 1998, p. 48, 550- 1, 174, 513, 655, 516.
14 Chang HM, But PPH. Pharmacology and Applications of Chinese Materia Medica, Vol. I, II. World Scientific, Singapore, 1988. p. 1119
15 Pan M. Cancer Treatment with Fu Zheng Pei Ben Principle. Fujian Science and Technology Publishing House, Fujian, 1992, p. 43- 4.
16 Cohen I. Preliminary Draft on the treatment of breast cancer with integrated Western and Chinese Medicine. Presented by Meridian Seminars 1995, p. 67.
17 Acupuncture. NIH Consensus Statement Online. Nov 3-5; 15(5):1-34, 1997
18 The Italian Group for Antiemetic Research: Dexamethasone, granisetron, or both for the prevention of nausea and vomiting during chemotherapy for cancer. N Engl J Med 332:1-5, 1995
19 Levitt M, Warr D, Yelle L, et al: Odansetron compared with dexamethasone and metoclopramide as antiemetics in the chemotherapy of breast cancer with cyclophosphamide, methotrexate, and fluorouracil. N Engl J Med 328:1081-1084, 1993.
20 Dundee JW, Chestnut WN, Ghaly RG et al: Traditional Chinese acupuncture: a potentially useful antiemetic? British Medical Journal 293:583-584, 1986
21 Dundee JW, Ghaly RG: Local anaesthesia blocks the antiemetic action of P6 acupuncture. Clinical Pharmacology and Therapeutics 50:78-80, 1991
22 Dundee JW, McMillan C: Positive evidence for P6 acupuncture antiemesis. Postgraduate Medical Journal 67:417-422, 1991
23 Dundee JW, McMillan C: Some problems encountered in the scientific evaluation of acupuncture antiemesis. Acupuncture in Medicine 10:2-8, 1992
24 Dundee JW, Yang J: Prolongation of the antiemetic action of P6 acupuncture by acupressure in patients having cancer chemotherapy. Journal of the Royal Society of Medicine 83:360-362, 1990
25 Dundee JW, Ghaly RG, Fitzpatrick KT, et al: Acupuncture prophylaxis of cancer chemotherapy-induced sickness. Journal of the Royal Society of Medicine 82:268-271, 1989
26 Dundee JW, Yang J, McMillan C: Non-invasive stimulation of P6 (Neiguan) antiemetic acupuncture point in cancer chemotherapy. Journal of the Royal Society of Medicine 84:210-212, 1991
27 Lewith GT, Vincent C: On the evaluation of the clinical effects of acupuncture: a problem reassessed and a framework for future research. The Journal of Alternative and Complementary Medicine 2:79-90, 1996
28 Wei Z: Clinical observation on therapeutic effect of acupuncture at St 36 for leukopenia, Journal of Traditional Chinese Medicine 18(2): 94- 95, 1998
29 Sun D, Wu Y and Peng Y: Treatment on 128 cases of leukocytopenia by acupuncture and massage. Shanghai J Acu Mox. 4: 23- 26, 1999
30 Zhou J, Li Z and Jin P: A clinical study on acupuncture for prevention and treatment of toxic side effects during radiotherapy and chemotherapy. Journal of Traditional Chinese Medicine 19(1): 16- 21, 1999
31 Wu B, Zhou R and He J: Current situation and prospect of researches on acupuncture mediating immunoresponses. Shanghai J Acu Mox. 1: 73- 76, 1999
32 Xu Z, Liu L, Xiu H et al: The influence of acupuncture on relationship between T lymphocyte subsets and estrogen in patients with mastoplasia. Shanghai J Acu Mox., 1998 (2): 13-15.)
33 ZhangD, Zheng X and Wang Q: Clinical study on climacteric syndrome treated by acupuncture and moxibustion. Shanghai J Acu Mox. 3: 29- 32, 1999
34 Yan J and Liang J: Auricular-plaster therapy for 89 cases of climacteric syndrome. Shanghai J Acu Mox. 1: 63- 64, 1998
35 Wu L and Zhou X: Menopausal syndrome treated by acupuncture. Journal of Traditional Chinese Medicine 18 (4): 259- 262, 1998
36 Hadden JW: The immunology of breast cancer. Prospects for immunotherapy. Clin. Immunother 4:249-330, 1995
37 Wiltschke C et al: Reduced mitogenic stimulation of peripheral blood mononuclear cells as a prognostic parameter for the course of breast cancer: a prospective longitudinal study. Br. J. Cancer 71:1292-1296, 1995.
38 Early Breast Cancer Trialists' Collaborative Group: Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 33 randomized trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Lancet 339:1-15;71-85, 1992.
39 Lin SY, Liu LM, Wu LC: The Effect of Shen mai injection on immune function in stomach cancer patients after chemotherapy. Chinese Journal of Integrated Traditional and Western Medicine, Aug, 15 (8): 451- 453, 1995
40 Shen R and Zhan Z: Clinical Study of the Use of Ginseng and Tang- Kuei Ten Combination in the Treatment of Leukopenia. International Journal of Oriental Medicine, 22 (1): 30- 31, 1997
41 Liu JQ, Wu DW: 58 cases of postoperative osteogenic sarcoma treated by chemotherapy combined with Chinese medicinal herbs. Zhong guo zhongxi yi jie he za zhi, 13 (3): 150- 152, 1993 (Translated by Amy Hanks)
42 Quasthoff S, Hartung HP. Chemotherapy-induced peripheral neuropathy. J Neurol. 2002 Jan;249(1):9-17.
43 Zhang J, Zhang P: Treatment of 56 cases of shingles by point injection therapy. Shanghai J Acu Mox. 1: 23- 24, 1999
44 Shan B and Shao S: The clinical observation on treating peripheral nerve injury by electroacupuncture. Shanghai J Acu Mox. 1(5): 24- 26, 1999
45 Galantino ML, Eke-Okoro ST, Findley TW et al. Use of noninvasive electroacupuncture for the treatment of HIVrelated peripheral neuropathy: a pilot study. J Altern Complement Med. 1999 Apr;5(2):135-42.
46 Abuaisha BB, Costanzi JB, Boulton AJ. Acupuncture for the treatment of chronic painful peripheral diabetic neuropathy: a long-term study. Diabetes Res Clin Pract. 1998 Feb;39(2):115-21.
47 Shan B and Shao S: The clinical observation on treating peripheral nerve injury by electroacupuncture. Shanghai J Acu Mox. 1(5): 24- 26, 1999
48 Zhen H. Li Y. Yuan S. Clinical observation on diabetic peripheral neuropathy treated by needling combined with drug. Shanghai J Acu Mox. 2000, 3(1): 13-6.
49 Li M. Wang X. Clinical observation on treatment of diabetic peripheral neuropathy with refined tianma duzhong capsule. J TCM 1999, 19(3): 182-4.
50 Valero V. Primary chemotherapy with docetaxel for the management of breast cancer. Oncology (Huntingt). 2002 Jun;16(6 Suppl 6):35-43.
51 Mamounas EP. NSABP Protocol B-27. Preoperative doxorubicin plus cyclophosphamide followed by preoperative or postoperative docetaxel. Oncology (Huntingt). 1997 Jun;11(6 Suppl 6):37-40.
52 Nbholtz JM, Pienkowski T, Mackey J et al. Phase III trial comparing TAC (docetaxel, doxorubicin, cyclophosphamide) with FAC 5- fluorouracil, doxorubicin, cyclophosphamide) in the adjuvant treatment of node positive breast cancer (BC) patients: interim analysis of the BCIRG 001 study. Program/ Proceedings of the American Society of Clinical Oncology Volume 21, May 2002 abs. 141, p.36a).
53 Physician Desk Reference, Nov. 2001).
54 Li Z, Ibrahim N. K. Wang M et al. Colitis in breast cancer patients treated with taxane based chemotherapy (TBC): M.D. Anderson Cancer Center experience. Program/ Proceedings of the American Society of Clinical Oncology Volume 21, May 2002 abs. 226 p.57a).
Supported in part by NIH/NCI P50CA 58207
About the Authors
Back to the Table of Contents
Isaac Cohen, L.Ac.,O.M.D.(American Acupuncture Center, Berkeley, CA) is one of the founders of the Complimentary and Alternative Medicine Program at the University of California at San Francisco ’s (UCSF) Carol Frank Buck Breast are Center. His private practice specialises in the treatment of breast cancer with the integration of Western and Chinese medicine. Isaac has spearheaded many clinical and laboratory studies to assess the biological activity and efficacy of Chinese herbs in the treatment of cancer.
Mary Tagliaferri , M.D.,L.Ac., (University of California at San Francisco)is one of the founders of the Complimentary and Alternative Medicine Program at the University of California at San Francisco ’s (UCSF) Carol Frank Buck Breast are Center. She opened the first traditional Chinese medicine clinic at UCSF. She is a co-Investigator on numerous clinical trials and laboratory studies to assess the effect of Chinese medicine in breast cancer. Mary is a breast cancer survivor.
Debu Tripathy , M.D. Professor of Medicine and Director, Breast Cancer Research Program University of Texas Southwestern Medical Center at Dallas He has been a principal investigator on numerous clinical trials assessing chemotherapeutic agents and biological oncogene-targeting treatments. Debu is one of the founders of the CAM research program at UCSF and is the principal investigator on number of trials to assess the effects of herbs for breast cancer.
|
|
Reprinted by permission from |
|
You are welcome to share this © article with friends, but do not forget to include the author name and web address. Permission needed to use articles on commercial and non commercial websites. Thank you. |